Literature DB >> 10869810

Induction of rat L-phosphoserine phosphatase by amyloid-beta (1-42) is inhibited by interleukin-11.

K Heese1, Y Nagai, T Sawada.   

Abstract

Alzheimer's disease (AD) is characterized by the presence of beta-amyloid (Abeta) protein deposits in the brain and increased Abeta (1-42) peptide production is thought to be one of the early events in the pathogenesis of AD that leads to progressive neurodegenerative processes and dementia. Using cDNA subtraction and reverse transcription-polymerase chain reaction, we examined the Abeta (1-42) peptide-induced gene expression in rat neuroblastoma B104 cells. In addition we hypothesized that interleukin-11 (IL-11) supports neuronal survival. We found that Abeta (1-42) activates L-phosphoserine phosphatase in neuronal cells which is inhibited by IL-11. Moreover, IL-11 inhibits Abeta (1-42)-induced neurotoxicity in a dose-dependent manner. Our study suggests that L-phosphoserine phosphatase may play a role in altered neuronal function in AD via enhancing glutamate-induced neurotoxicity by D-serine and the IL-11 receptor system may act as a neuroprotective cytokine in human brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869810     DOI: 10.1016/s0304-3940(00)01197-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease.

Authors:  Pamela Sparks Stein; Michelle J Steffen; Charles Smith; Gregory Jicha; Jeffrey L Ebersole; Erin Abner; Dolph Dawson
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

2.  Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay.

Authors:  Xiaoyi Yang; Eying Chen; Hengguang Jiang; Karen Muszynski; Raymond D Harris; Steven L Giardina; Matthias Gromeier; Gautam Mitra; Gopalan Soman
Journal:  J Virol Methods       Date:  2008-11-08       Impact factor: 2.014

3.  Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration.

Authors:  Daniela Galimberti; Eliana Venturelli; Chiara Fenoglio; Ilaria Guidi; Chiara Villa; Luigi Bergamaschini; Francesca Cortini; Diego Scalabrini; Pierluigi Baron; Carlo Vergani; Nereo Bresolin; Elio Scarpini
Journal:  J Neurol       Date:  2008-01-23       Impact factor: 4.849

4.  Effect of Tiantai No.1 on beta-amyloid-induced neurotoxicity and NF-kappa B and cAMP responsive element-binding protein.

Authors:  Zheng-zhi WU; Andrew C J Huang; Jean de Vellis; Ying-hong LI
Journal:  Chin J Integr Med       Date:  2008-12-12       Impact factor: 1.978

5.  Searching for an endogenous anti-Alzheimer molecule: identifying small molecules in the brain that slow Alzheimer disease progression by inhibition of ß-amyloid aggregation.

Authors:  Autumn R Meek; Gordon A Simms; Donald F Weaver
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

6.  Identification of rTid-1, the rat homologue of the drosophila tumor suppressor l(2)tid gene.

Authors:  Masako Fujita; Yasuo Nagai; Tohru Sawada; Klaus Heese
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

7.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31

Review 8.  D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain.

Authors:  J-M Billard
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

9.  Igf1 and Pacap rescue cerebellar granule neurons from apoptosis via a common transcriptional program.

Authors:  Barbara Maino; Velia D'Agata; Cinzia Severini; Maria T Ciotti; Pietro Calissano; Agata Copani; Yi-Chien Chang; Charles DeLisi; Sebastiano Cavallaro
Journal:  Cell Death Discov       Date:  2015-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.